Tyzivumab

BIOLOGICAL2 trials

Sponsors

Tychan Pte Ltd.

Conditions

Treatment of Acute Zika Virus Infection

Phase 1

Safety and Tolerability of an Antibody Against Zika Virus (Tyzivumab) in Humans

CompletedNCT03443830

Tychan Pte Ltd.Treatment of Acute Zika Virus Infection

Start: 2018-02-08End: 2018-12-04Updated: 2019-04-10

Safety and Tolerability of an Antibody Against Zika Virus (Tyzivumab) in ZIKV Infected Patients

WithdrawnNCT03776695

Tychan Pte Ltd.Treatment of Acute Zika Virus Infection

Start: 2018-10-09End: 2022-01-05Updated: 2022-03-24